Sanofi, Google’s Verily Enter Diabetes JV To Produce Joined Up Solutions

Sanofi’s diabetes head says French drug maker’s JV pact with Google’s Verily will combine novel therapies for the condition with cutting edge technologies to produce better focused, outcome-based combinations.

Stefan Oelrich
Sanofi Global Diabetes Franchise Head Stefan Oelrich • Source: Sanofi

A joint venture being established by Sanofi and Google parent Alphabet aims to combine medicines, devices and software into a joined up portfolio of product offerings for diabetes patients around the world, according to the head of the French drug maker’s global diabetes franchise.

The US-based JV, named Onduo, was announced Sept 12 as a unique alliance focus on helping type 2 diabetes patients better plan their day to day medication management and habits

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Business